Clinical Trials Logo

Clinical Trial Summary

Investigating four different treatment of MTC or FMT


Clinical Trial Description

The purpose of this research study is to compare two different treatments for patients with recurrent Clostridiodies difficile infections: MTC01 vs fecal microbiota transplantation (FMT). FMT is the transfer of bacteria from a healthy donor's colon to a recipient's colon. To do this, stool from a healthy donor is blended with salt water and made into a liquid solution rich in bacteria. This solution is sprayed into the recipient's colon during a colonoscopy. This treatment is now considered standard medical care for recurrent Clostridioides difficile infections. One FMT dose contains the entire collection of microbes in a healthy donor and is made up of billions of microbes. Each dose of FMT is different from the next and it is unknown exactly what microbes are present in each dose. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05911997
Study type Interventional
Source Icahn School of Medicine at Mount Sinai
Contact Sari Feldman, MS
Phone 212-824-7669
Email sari.feldman@mssm.edu
Status Recruiting
Phase Phase 1
Start date January 8, 2024
Completion date July 25, 2025